Showing results (241-250 of 346) with videos related to

Sort By:
Pageof 35
BMJ Open|June 25, 2013
Azithromycin and survival in Streptococcus pneumoniae pneumonia: a retrospective studyAndrew F Shorr, Marya D Zilberberg, Jason Kan, et al.
Chest|December 30, 2009
Association between a silver-coated endotracheal tube and reduced mortality in patients with ventilator-associated pneumoniaBekele Afessa, Andrew F Shorr, Antonio R Anzueto, et al.
Journal of Hospital Medicine|November 1, 2011
Severe acute hypertension among inpatients admitted from the emergency departmentAndrew F Shorr, Marya D Zilberberg, Xiaowu Sun, et al.
Medical Care|April 23, 2013
Development and validation of a mortality risk-adjustment model for patients hospitalized for exacerbations of chronic obstructive pulmonary diseaseYing P Tabak, Xiaowu Sun, Richard S Johannes, et al.
Critical Care (London, England)|October 1, 2009
Candidemia on presentation to the hospital: development and validation of a risk scoreAndrew F Shorr, Ying P Tabak, Richard S Johannes, et al.
Critical Care Medicine|July 30, 2014
Using the number needed to treat to assess appropriate antimicrobial therapy as a determinant of outcome in severe sepsis and septic shockCristina Vazquez-Guillamet, Michael Scolari, Marya D Zilberberg, et al.
Critical Care Explorations|April 13, 2022
Inappropriate Empiric Therapy Impacts Complications and Hospital Resource Utilization Differentially Among Different Types of Bacterial Nosocomial Pneumonia: A Cohort Study, United States, 2014-2019Marya D Zilberberg, Brian H Nathanson, Laura A Puzniak, et al.
Chest|January 23, 2015
The Role for Optical Density in Heparin-Induced Thrombocytopenia: A Cohort StudyChee M Chan, Christian J Woods, Theodore E Warkentin, et al.
Critical Care Medicine|June 3, 2026
Epidemiology and Outcomes Among Adults With Severe Community-Acquired Bacterial Pneumonia Hospitalized in the United States, 2021-2024Marya D Zilberberg, Mike Greenberg, Brian H Nathanson, et al.
Antimicrobial Agents and Chemotherapy|April 22, 2015
Pharmacokinetics of ceftaroline in normal body weight and obese (classes I, II, and III) healthy adult subjectsJulie Ann Justo, Stockton M Mayer, Manjunath P Pai, et al.
Pageof 35